P
Protagonist Therapeutics D
D
PTGX
154.396
USD
3.69
(2.45%)
قبل الجلسة·152.600USD-1.796(-1.16%)
حجم التداول
14,190
الربح لكل سهم
4
العائد الربحي
-
P/E
150
حجم السوق
9,990,700,371
المقالات
العنوان: Protagonist Therapeutics
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
